Oncolytics Biotech, Inc. (ONCY)
0.3696
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
0.37
0.00 (0.00%)
After-Hours: 19:59
Oncolytics Biotech Market Cap : 46.07M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 46.37M |
| November 11, 2026 | 51.30M |
| November 10, 2026 | 47.59M |
| November 09, 2026 | 50.81M |
| November 06, 2026 | 54.77M |
| November 05, 2026 | 55.94M |
| November 04, 2026 | 52.95M |
| November 03, 2026 | 48.61M |
| November 02, 2026 | 49.86M |
| October 30, 2026 | 53.02M |
| October 29, 2026 | 53.31M |
| October 28, 2026 | 55.04M |
| October 27, 2026 | 57.62M |
| October 26, 2026 | 58.98M |
| October 23, 2026 | 62.61M |
| October 22, 2026 | 62.34M |
| October 21, 2026 | 63.74M |
| October 20, 2026 | 62.14M |
| October 19, 2026 | 61.86M |
| October 16, 2026 | 62.08M |
| October 15, 2026 | 68.25M |
| October 14, 2026 | 67.08M |
| October 13, 2026 | 61.07M |
| October 12, 2026 | 58.99M |
| October 09, 2026 | 69.42M |
| Date | Value |
|---|---|
| October 08, 2026 | 67.85M |
| October 07, 2026 | 74.26M |
| October 06, 2026 | 74.53M |
| October 05, 2026 | 74.40M |
| October 02, 2026 | 78.65M |
| October 01, 2026 | 79.92M |
| September 30, 2026 | 83.28M |
| September 29, 2026 | 84.07M |
| September 28, 2026 | 82.63M |
| September 25, 2026 | 85.16M |
| September 24, 2026 | 84.65M |
| September 23, 2026 | 84.32M |
| September 22, 2026 | 88.90M |
| September 21, 2026 | 95.51M |
| September 18, 2026 | 95.97M |
| September 17, 2026 | 95.97M |
| September 16, 2026 | 95.82M |
| September 15, 2026 | 97.22M |
| September 14, 2026 | 101.29M |
| September 11, 2026 | 92.92M |
| September 10, 2026 | 96.22M |
| September 09, 2026 | 99.09M |
| September 08, 2026 | 100.33M |
| September 04, 2026 | 105.09M |
| September 03, 2026 | 106.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 37.23B |
| Arrowhead Pharmaceuticals, Inc. | 6.741B |
| Sangamo Therapeutics, Inc. | 45.57M |
| Sarepta Therapeutics, Inc. | 1.722B |
| Anixa Biosciences, Inc. | 91.13M |
Market Cap Related Metrics
| PEG Ratio | -0.0318 |
| Price | 0.3696 |
| Earnings Yield | -73.73% |
| PEGY Ratio | -0.0318 |